Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dundee University Joins ITI Life Sciences’ Stem Cell Technologies R&D Programme

Published: Friday, May 04, 2007
Last Updated: Friday, May 04, 2007
Bookmark and Share
The University will provide its screening expertise, which will be instrumental in developing additional technologies towards the programme’s objectives.

ITI Life Sciences has announced that it has reached its first technical milestone in its Stem Cell Technologies (SCT) R&D programme, and as a result Dundee University has joined the £9.5 million programme, which started in January 2007.

Dundee University will join the programme’s other research providers, Swedish biotech firm Cellartis AB and the University of Glasgow, in a collaborative effort to develop technologies that will enable automated processes to produce high volumes of high quality human stem cells.

According to ITI Life Sciences, this capability does not exist anywhere in the world and its development will put Scotland at the forefront of stem cell research as well as bringing closer the use of stem cells as therapeutics.

The initial phase of the programme has focused on developing optimal conditions under which human embryonic stem (hES) cells can be tested for their ability to differentiate into specific cells. Having achieved this crucial step, ITI Life Sciences is now in a position to bring in Dundee University’s screening expertise, which will be instrumental in developing additional technologies towards the programme’s objectives.

Dr Eleanor Mitchell, ITI Life Sciences’ acting CEO, said: “We are extremely pleased to have reached this milestone in our Stem Cell Technologies programme so quickly. This technical advance allows us to progress our programme quicker than expected and to bring in an additional excellent research provider in the form of Dundee University.

“Stem cell research offers huge potential for the life sciences sector in Scotland. Scottish academic studies in this field, as well as the location of a growing number of international stem cell players here means it is viewed as one of the country’s major strengths. The ITI programme aims to accelerate Scottish research and reinforce its prominence and reputation in this important area.”

Professor Julie Frearson, University of Dundee, said: “Novel technologies, such as these under development within the ITI programme, require expertise across a range of disciplines. The ITI programme provides a great opportunity for groups with such complementary skills to collaborate effectively in a situation that otherwise could not exist in any single emerging company or university.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
New Biomarker to Assess Stem Cells Developed
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Edited Stem Cells Offer Hope of Precision Therapy for Blindness
Findings raise the possibility of treating blinding eye diseases using a patient's own corrected cells as replacement tissue.
Hacking the Programs of Cancer Stem Cells
All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.
Newfound Strength in Regenerative Medicine
A promising new approach uses direct mechanical stimulation to repair severely damaged skeletal muscles.
Mapping out Cell Conversion
Researchers develop algorithm that takes the field of cell reprogramming forward.
Donor's Genotype Controls the Differentiation of IPS Cells
Pluripotent stem cells derived from different cell types are equally susceptible to reprogramming, indicates a recent study by the University of Helsinki and the National Institute for Health and Welfare, Finland. However, the genotype of the donor strongly influences the differentiation of the stem cell.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!